From: Safety and efficacy of belimumab after B cell depletion therapy in systemic LUPUS erythematosus (BEAT-LUPUS) trial: statistical analysis plan
Dataset
Time point
Log mean
Log SD
Correlation
Isenberg (n = 67)
Baseline
6.036
1.393
Follow-up
5.189
1.500
0.612
Carter (n = 35)
5.091
1.676
5.225
1.781
0.527